FIXED DOSE COMBINATION FORMULATION OF EFLORNITHINE AND SULINDAC

MA43114AUndetermined Publication Date: 2018-09-05CANCER PREVENTION PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA43114
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2016-10-28
Filing Date
2016-10-31
Publication Date
2018-09-05
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.